查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088750

即時血糖監測市場：依產品類型、測試類型、技術、可攜性、最終用戶和通路分類－2026-2032年全球市場預測

Point-of-Care Glucose Testing Market by Product Type, Test Type, Technology, Portability, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，即時血糖監測市場規模將達到 62.9 億美元，複合年成長率為 4.83%。

主要市場統計數據
基準年 2025 45.2億美元
預計年份：2026年 47.3億美元
預測年份 2032 62.9億美元
複合年成長率 (%) 4.83%

介紹即時血糖檢測市場

床邊血糖檢測可在醫院病床、診所、急診室、長期照護機構、藥局和家庭中快速監測血糖值。其戰略價值與全球糖尿病負擔密切相關。根據國際糖尿病聯盟（IDF）統計，2021年全球糖尿病成人患者人數為5.37億，預計到2030年將達到6.43億，到2045年將達到7.83億。

即時血糖監測的變革性變化

目前，我們正從獨立的血糖儀轉向聯網、品管和可互通的檢測生態系統。醫院越來越重視將設備與電子健康記錄、操作員鎖定功能、基於條碼的患者身份識別、批次追蹤和集中式資料管理整合，以減少轉錄錯誤並加強審計合規性。

人工智慧（AI）的累積影響

人工智慧 (AI) 為床邊血糖監測增添價值，並非取代檢驗的生化測量，而是提升工作流程的智慧化程度。 AI 驅動的分析可以識別異常結果模式、檢測品管偏差、指出操作人員培訓中的不足，並協助審查異常事件，從而幫助臨床醫生識別存在低血糖或高血糖風險的患者。

全球市場的關鍵區域洞察

根據國際糖尿病聯盟（IDF）的數據，亞太地區是重點關注區域，其中中國和印度的糖尿病患者人數位居世界前列。同時，日本、韓國和澳洲已廣泛採用標準化的數位醫療基礎設施和以品質為中心的診療路徑。北美憑藉其醫院間的協作、CLIA豁免檢測、FDA監管、較高的糖尿病管理意識以及支持臨床和家庭血糖監測的完善報銷機制，繼續保持其作為標竿市場的地位。

針對特定群體的關鍵策略定位洞察

東協地區的需求主要受糖尿病盛行率上升、都市化、基層醫療網路擴張以及政府為改善非傳染性疾病管理所做的努力所驅動，因此，採購中對價格合理的血糖儀和可靠試紙的供應日益重視。海灣合作理事會（GCC）國家則優先考慮適用於醫院現代化、糖尿病預防、大規模篩檢、高通量檢測設施和數位化醫療模式的互聯即時檢測（PoC）平台。

各國在即時血糖監測的關鍵見解。

美國在體外診斷市場佔據領先地位，這得益於FDA監管的醫院血糖監測系統、CLIA豁免的檢測環境、完善的糖尿病篩檢基礎設施以及CDC報告的大量糖尿病診斷病例。加拿大則強調省級採購、慢性病管理以及都市區社區間公平的醫療服務取得。墨西哥和巴西正在擴大旨在提供社區糖尿病護理、方便患者獲取藥物以及早期診斷和持續監測的公共衛生舉措。在英國、德國、法國、義大利和西班牙，公共醫療保險報銷、採購規範、人口老化、結構化的糖尿病照護路徑以及歐盟或英國對體外診斷的法律規範是推動市場發展的主要因素。

為行業領導者提供的實用建議

產業領導企業不僅應在醫療設備的價格上競爭，更應在臨床可靠性上競爭。優先措施包括：依照 ISO 15197 標準證明準確性；支援醫院級互聯互通；實施基於條碼的病患和操作人員識別；簡化員工培訓；以及提供與電子健康記錄和品管系統整合的安全資料管理。

調查方法

本執行摘要基於來自公共衛生、監管和標準可靠來源的二手研究，包括國際糖尿病聯盟 (IDF)、世界衛生組織 (WHO)、美國疾病控制與預防中心 (CDC)、美國食品藥物管理局(FDA)、ISO 15197 指南、CLIA資訊來源和歐盟 IVDR（體外診斷醫療設備法規）框架。

結論

床邊血糖監測仍然是糖尿病管理和急診決策中的關鍵要素。推動其普及的因素包括糖尿病患者人數的增加、人口老化、分散式醫療模式的普及、醫院品質要求以及臨床上對快速且可追溯的血糖結果的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 即時血糖監測市場：依產品類型分類

  • 連續血糖監測設備
    • 間歇掃描法
    • 即時的
  • 血糖儀
  • 感應器
    • 酵素法
    • 光學
  • 軟體應用
  • 測試條

第8章 即時血糖監測市場：依檢測類型分類

  • 侵襲型
  • 微創
  • 非侵入性

第9章 即時血糖監測市場：依技術分類

  • 比色法
  • 電化學公式
  • 光度學

第10章：即時血糖監測市場：以便攜性分類

  • 工作檯面
  • 可攜式的

第11章 即時血糖監測市場：依最終用戶分類

  • 門診手術中心
  • 診斷檢查室
    • 醫院檢查室
    • 獨立檢測實驗室
  • 居家照護
    • 輔助居家照護
    • 自我測量
  • 醫院和診所
    • 大型醫院
    • 小規模診所

第12章 即時血糖監測市場：依通路分類

  • 直銷
  • 醫院藥房
  • 網路藥房
    • 製造商網站
    • 第三方市場
  • 零售藥房

第13章：即時血糖監測市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 即時血糖監測市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 即時血糖監測市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • ARKRAY, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Dexcom, Inc.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • GlySens, Inc.
  • HemoCue AB
  • i-SENS, Inc.
  • iHealth Labs Inc.
  • LifeScan, Inc.
  • Medtronic plc
  • Nipro Corporation
  • Nova Biomedical Corporation
  • PTS Diagnostics
  • Sanofi SA
  • Senseonics Holdings, Inc.
  • Sinocare Inc.
  • Terumo Corporation
  • Trividia Health, Inc.
  • Ypsomed Holding AG
Product Code: MRR-B9334AD6C44F

The Point-of-Care Glucose Testing Market is projected to grow by USD 6.29 billion at a CAGR of 4.83% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 4.52 billion
Estimated Year [2026] USD 4.73 billion
Forecast Year [2032] USD 6.29 billion
CAGR (%) 4.83%

Point-of-Care Glucose Testing Market Introduction

Point-of-care glucose testing enables rapid blood glucose measurement at the bedside, in clinics, emergency departments, long-term care settings, pharmacies, and homes. Its strategic value is tied to the global diabetes burden: the International Diabetes Federation reported 537 million adults living with diabetes in 2021, with projections of 643 million by 2030 and 783 million by 2045.

For healthcare systems, point-of-care glucose testing supports faster clinical decisions, inpatient glycemic control, hypoglycemia detection, and decentralized chronic disease management. Market relevance is reinforced by accuracy expectations under ISO 15197:2013, CLIA-waived testing pathways in the United States, FDA oversight for glucose monitoring systems, and stronger digital connectivity requirements across hospital glucose meter fleets.

Transformative Shifts in Point-of-Care Glucose Testing

The landscape is shifting from standalone glucose meters toward connected, quality-controlled, and interoperable testing ecosystems. Hospitals increasingly prioritize device integration with electronic health records, operator lockout, barcode patient identification, lot tracking, and centralized data management to reduce transcription errors and strengthen audit readiness.

A second transformation is the movement of glucose monitoring closer to the patient. Retail clinics, community health programs, ambulatory care sites, and home-based care are expanding access, while regulatory scrutiny remains high because insulin dosing and urgent treatment decisions can be made from point-of-care results. This makes analytical accuracy, cybersecurity, supply continuity, quality control compliance, and staff training core purchase criteria.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is adding value around point-of-care glucose testing by improving workflow intelligence rather than replacing validated biochemical measurement. AI-enabled analytics can flag unusual result patterns, detect quality control drift, identify operator training gaps, support exception review, and help clinicians recognize patients at risk of hypo- or hyperglycemia.

The cumulative impact is strongest when glucose meter data, insulin administration records, nutrition data, comorbidities, and electronic health record information are analyzed together. However, industry leaders must validate algorithms, control bias, protect patient data, preserve clinician oversight, and align AI-enabled functions with FDA software guidance, EU IVDR expectations, data protection rules, and hospital governance requirements.

Key Regional Insights Across Global Markets

Asia-Pacific is a high-priority region because China and India have among the world's largest diabetes populations according to International Diabetes Federation data, while Japan, South Korea, and Australia show strong adoption of regulated digital health infrastructure and quality-focused care pathways. North America remains a benchmark market due to hospital connectivity, CLIA-waived testing, FDA oversight, high awareness of diabetes management, and established reimbursement structures supporting clinical and home-based glucose monitoring.

Europe is shaped by EU IVDR transition requirements, procurement standardization, national diabetes programs, and demand for interoperable medical devices across public health systems. Latin America, led by Brazil and Mexico, is expanding decentralized diabetes care and pharmacy-based access but remains sensitive to affordability, strip availability, and distribution reliability. The Middle East, especially GCC health systems, is investing in diabetes screening, hospital modernization, and premium connected infrastructure, while Africa faces the greatest access gap, making low-cost, rugged, battery-efficient, and training-light glucose testing essential for primary care and outreach settings.

Key Group Insights for Strategic Positioning

ASEAN demand is supported by rising diabetes prevalence, urbanization, expanding primary care networks, and government efforts to improve noncommunicable disease management, with procurement often favoring affordable meters and dependable test strip supply. The GCC prioritizes hospital modernization, diabetes prevention initiatives, population screening, and connected point-of-care platforms suited to high-throughput facilities and digitally enabled care models.

The European Union is driven by IVDR compliance, interoperability, public procurement discipline, and strong clinical governance around in vitro diagnostic performance. BRICS markets combine large patient pools with uneven access, creating demand for scalable distribution, localized manufacturing, and cost-sensitive product tiers. G7 countries lead in quality systems, digital integration, reimbursement maturity, and evidence-based clinical adoption, while NATO members increasingly emphasize resilient supply chains, cybersecurity, standardization, and deployable medical testing capability for civilian and emergency preparedness needs.

Key Country Insights in Point-of-Care Glucose Testing

The United States leads through FDA-regulated hospital glucose systems, CLIA-waived testing settings, extensive diabetes screening infrastructure, and a large diagnosed diabetes population reported by the CDC. Canada emphasizes provincial purchasing, chronic disease management, and equitable access across urban and remote communities. Mexico and Brazil are expanding community-based diabetes care, pharmacy access, and public health initiatives aimed at earlier diagnosis and ongoing monitoring. The United Kingdom, Germany, France, Italy, and Spain are shaped by public reimbursement, procurement discipline, aging populations, structured diabetes care pathways, and EU or UK regulatory oversight for in vitro diagnostics.

Russia remains influenced by import substitution, procurement localization, and supply resilience. China and India are scale markets with major diabetes burdens, rising diagnosis rates, expanding hospital networks, and fast-growing domestic device ecosystems. Japan, Australia, and South Korea prioritize quality, aging-population care, connected medical technology, and strong regulatory compliance, making them attractive for premium point-of-care glucose testing platforms that combine accuracy, traceability, and digital integration.

Actionable Recommendations for Industry Leaders

Industry leaders should compete on clinical reliability, not device price alone. Priority actions include demonstrating ISO 15197-aligned accuracy, supporting hospital-grade connectivity, enabling barcode-based patient and operator identification, simplifying staff training, and offering secure data management that integrates with electronic health records and quality control systems.

Manufacturers should also diversify test strip supply, strengthen cybersecurity controls, localize distribution in high-growth regions, and design tiered portfolios for hospitals, clinics, pharmacies, long-term care facilities, and home users. Commercial teams can improve adoption by publishing real-world workflow evidence, supporting regulatory transitions, training care teams, and partnering with diabetes screening and chronic disease management programs.

Research Methodology

This executive summary is based on secondary research from recognized public health, regulatory, and standards sources, including the International Diabetes Federation, World Health Organization, U.S. Centers for Disease Control and Prevention, U.S. FDA, ISO 15197 guidance, CLIA information, and EU IVDR frameworks.

Insights were synthesized using market triangulation across disease burden, care-setting adoption, regulatory requirements, technology trends, regional healthcare infrastructure, and digital health readiness. Findings emphasize verified drivers, compliance factors, and strategic implications rather than unsupported revenue claims, market sizing, market share, or forecasting.

Conclusion

Point-of-care glucose testing remains a critical component of diabetes management and acute-care decision-making. Adoption is supported by the rising diabetes population, aging demographics, decentralized care models, hospital quality requirements, and the clinical need for rapid, traceable glucose results.

The next phase of competition will center on accuracy, digital interoperability, AI-supported quality intelligence, supply resilience, cybersecurity, and regulatory readiness. Organizations that align affordability with connected clinical-grade performance are best positioned to meet sustainable demand across mature and emerging healthcare systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Point-of-Care Glucose Testing Market, by Product Type

  • 7.1. Continuous Glucose Monitoring Devices
    • 7.1.1. Intermittently Scanned
    • 7.1.2. Real Time
  • 7.2. Glucose Meters
  • 7.3. Sensors
    • 7.3.1. Enzymatic
    • 7.3.2. Optical
  • 7.4. Software Apps
  • 7.5. Test Strips

8. Point-of-Care Glucose Testing Market, by Test Type

  • 8.1. Invasive
  • 8.2. Minimally Invasive
  • 8.3. Non Invasive

9. Point-of-Care Glucose Testing Market, by Technology

  • 9.1. Colorimetric
  • 9.2. Electrochemical
  • 9.3. Photometric

10. Point-of-Care Glucose Testing Market, by Portability

  • 10.1. Benchtop
  • 10.2. Portable

11. Point-of-Care Glucose Testing Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Laboratories
    • 11.2.1. Hospital Based Labs
    • 11.2.2. Independent Labs
  • 11.3. Home Care
    • 11.3.1. Assisted Home Care
    • 11.3.2. Self Monitoring
  • 11.4. Hospitals & Clinics
    • 11.4.1. Large Hospitals
    • 11.4.2. Small Clinics

12. Point-of-Care Glucose Testing Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Hospital Pharmacies
  • 12.3. Online Pharmacies
    • 12.3.1. Manufacturer Websites
    • 12.3.2. Third Party Marketplaces
  • 12.4. Retail Pharmacies

13. Point-of-Care Glucose Testing Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Point-of-Care Glucose Testing Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Point-of-Care Glucose Testing Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Acon Laboratories, Inc.
  • 17.3. AgaMatrix, Inc.
  • 17.4. ARKRAY, Inc.
  • 17.5. Ascensia Diabetes Care Holdings AG
  • 17.6. B. Braun Melsungen AG
  • 17.7. Becton, Dickinson and Company
  • 17.8. Dexcom, Inc.
  • 17.9. EKF Diagnostics Holdings plc
  • 17.10. F. Hoffmann-La Roche Ltd.
  • 17.11. GlySens, Inc.
  • 17.12. HemoCue AB
  • 17.13. i-SENS, Inc.
  • 17.14. iHealth Labs Inc.
  • 17.15. LifeScan, Inc.
  • 17.16. Medtronic plc
  • 17.17. Nipro Corporation
  • 17.18. Nova Biomedical Corporation
  • 17.19. PTS Diagnostics
  • 17.20. Sanofi S.A.
  • 17.21. Senseonics Holdings, Inc.
  • 17.22. Sinocare Inc.
  • 17.23. Terumo Corporation
  • 17.24. Trividia Health, Inc.
  • 17.25. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTERMITTENTLY SCANNED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTERMITTENTLY SCANNED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTERMITTENTLY SCANNED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL REAL TIME MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL REAL TIME MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL REAL TIME MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GLUCOSE METERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GLUCOSE METERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GLUCOSE METERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SENSORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SENSORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SENSORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENZYMATIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENZYMATIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENZYMATIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL OPTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL OPTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL OPTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SOFTWARE APPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SOFTWARE APPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SOFTWARE APPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TEST STRIPS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TEST STRIPS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TEST STRIPS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MINIMALLY INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL NON INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL NON INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL NON INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ELECTROCHEMICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHOTOMETRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHOTOMETRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHOTOMETRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BENCHTOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BENCHTOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BENCHTOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL HOSPITAL BASED LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INDEPENDENT LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INDEPENDENT LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INDEPENDENT LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ASSISTED HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ASSISTED HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ASSISTED HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SELF MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SELF MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SELF MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL LARGE HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL LARGE HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL LARGE HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SMALL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SMALL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SMALL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL HOSPITAL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL THIRD PARTY MARKETPLACES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL THIRD PARTY MARKETPLACES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL THIRD PARTY MARKETPLACES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL RETAIL PHARMACIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 200. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 201. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 204. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 209. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 210. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. GCC POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 239. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 240. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 243. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 248. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 252. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 256. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 258. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 259. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 261. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 262. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 264. NATO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 279. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 282. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 283. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 285. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 286. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 288. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 289. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 290. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. CANADA POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 292. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 293. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 294. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 295. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 296. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 299. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 301. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 302. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 303. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 304. MEXICO POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 305. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 308. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 309. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 310. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 311. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 312. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 313. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 314. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 315. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 316. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 317. BRAZIL POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 321. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY SENSORS, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED KINGDOM POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 331. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 332. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 333. GERMANY POINT-OF-CARE GLUCOSE TESTING MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 334. GERMANY POINT-OF-CARE GLUCOSE TEST